Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia

Not Applicable

Completed

Conditions: Insomnia
Schizoaffective Disorder
Schizophrenia
Sleep Disorders

Interventions: Drug: Placebo
Drug: Eszopiclone

First Posted Date: 2008-03-28

Last Posted Date: 2015-07-16

Lead Sponsor: Yale University

Target Recruit Count: 39

Registration Number: NCT00645944

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

GABA (Gamma Amino Butyric Acid) Medication for Tobacco

Early Phase 1

Completed

Conditions: Nicotine Dependence

Interventions: Drug: pregabalin
Other: cigarettes

First Posted Date: 2008-03-26

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 24

Registration Number: NCT00644137

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence

Phase 2

Completed

Conditions: PTSD
Alcohol Dependence

Interventions: Other: modified CPT-C

First Posted Date: 2008-03-20

Last Posted Date: 2016-03-21

Lead Sponsor: Yale University

Target Recruit Count: 9

Registration Number: NCT00639288

Locations: 🇺🇸
VA Connecticut Healthcare System - West Haven Campus, West Haven, Connecticut, United States

Safety of Sports for Patients With Implantable Cardioverter-Defibrillators

Completed

Conditions: Heart Arrhythmias

First Posted Date: 2008-03-18

Last Posted Date: 2015-06-11

Lead Sponsor: Yale University

Target Recruit Count: 400

Registration Number: NCT00637754

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Washington University, St. Louis, Missouri, United States
🇧🇪
UZ Antwerpen, Edegem, Belgium

and more 51 locations

Ziprasidone in the Psychosis Prodrome

Phase 2

Completed

Conditions: Psychosis Prodrome

Interventions: Drug: placebo
Drug: ziprasidone

First Posted Date: 2008-03-14

Last Posted Date: 2023-03-27

Lead Sponsor: Yale University

Target Recruit Count: 51

Registration Number: NCT00635700

Locations: 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
🇺🇸
Beth Israel Deaconess Hospital, Boston, Massachusetts, United States
🇺🇸
University of Massachusetts, Worcester, Massachusetts, United States

and more 8 locations

Ethyl-EPA Treatment of Prodromal Patients

Phase 2

Completed

Conditions: Schizophrenia Prodrome

Interventions: Drug: ethyl-eicosapentaenoic acid

First Posted Date: 2008-03-13

Last Posted Date: 2014-05-22

Lead Sponsor: Yale University

Target Recruit Count: 7

Registration Number: NCT00634361

Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy Subjects

Not Applicable

Completed

Conditions: Alcohol Dependence

Interventions: Drug: D-Cycloserine PO and Glycine IV
Drug: Placebo D-Cycloserine PO and placebo Glycine IV
Drug: Placebo D-Cycloserine PO and Glycine IV
Drug: D-Cycloserine PO and placebo Glycine IV

First Posted Date: 2008-03-13

Last Posted Date: 2016-12-16

Lead Sponsor: Yale University

Target Recruit Count: 57

Registration Number: NCT00635102

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Clinical Trial of Integrated Treatment for Pain and Opioid Dependence

Phase 1

Completed

Conditions: Opiate Dependence
Chronic Pain

Interventions: Behavioral: CBT
Drug: Buprenorphine
Other: Educational Counseling
Other: Physician Management

First Posted Date: 2008-03-13

Last Posted Date: 2021-08-02

Lead Sponsor: Yale University

Target Recruit Count: 90

Registration Number: NCT00634803

Locations: 🇺🇸
Methadone Research Unit, New Haven, Connecticut, United States

The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers

Not Applicable

Completed

Conditions: Smoking

Interventions: Drug: Placebo
Drug: Cycloserine

First Posted Date: 2008-03-11

Last Posted Date: 2012-04-11

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT00633256

Locations: 🇺🇸
West Haven VA, West Haven, Connecticut, United States

Effective Treatment of Hepatitis C in Substance Users

Not Applicable

Completed

Conditions: Opiate Dependence
Hepatitis C

Interventions: Procedure: Modified Directly Observed Therapy (mDOT)
Procedure: Self-Administered Therapy (SAT)

First Posted Date: 2008-03-11

Last Posted Date: 2013-01-03

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT00633243

Locations: 🇺🇸
South Central Rehabilitation Agency, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy